Pricing

Celator Pharmaceuticals, Inc. (CPXX)

followers ·
Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Scott T. Jackson
Employees:
25
303B COLLEGE ROAD EAST, PRINCETON, NJ, 08540
(609) 243-0123

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • CELATOR PHARMACEUTICALS INC.
  • CELATOR PHARMACEUTICALS INC.
Celator Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapies to treat cancer. Its proprietary drug ratio technology platform, CombiPlex, enables the rational design and rapid evaluation of optimized combinations in...
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available